4.6 Article

Racial and Ethnic Disparities in the Obesity Paradox

Journal

AMERICAN JOURNAL OF KIDNEY DISEASES
Volume 72, Issue 5, Pages S26-S32

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2018.06.024

Keywords

-

Funding

  1. Abbott
  2. Abbvie
  3. Alexion
  4. Amgen
  5. American Society of Nephrology
  6. Astra-Zeneca
  7. AVEO
  8. Chugai
  9. DaVita
  10. Fresenius
  11. Genetech
  12. Haymarket Media
  13. Hospira
  14. Kabi
  15. Keryx
  16. NIH
  17. National Kidney Foundation
  18. Relypsa
  19. Resverlogix
  20. Sanofi
  21. Shire
  22. Vifor
  23. ZS-Pharma
  24. VA ORD
  25. Novartis
  26. VA

Ask authors/readers for more resources

Obesity is a major risk factor for cardiovascular disease and worse survival in the general population. However, in patients with end-stage renal disease (ESRD), higher body mass index and indexes of body fat and muscle are associated with better survival. Furthermore, these associations, which some have described as the obesity paradox, are more consistent in African American patients being treated with hemodialysis when compared with other racial-ethnic groups. This is in view of data indicating that although the rate of progression to ESRD is faster in African American patients, they have a survival advantage after transition to ESRD when compared with their white counterparts. These observations indicate that there may be significant interaction between race/ethnicity and association of body mass index with outcomes in patients with ESRD. In addition, it is possible that mechanisms underlying improved survival in African American hemodialysis patients are partly related to the association of body mass index with outcomes observed in this patient population. Some of these potential mechanisms may include comparatively reduced risk for protein-energy wasting and malnutrition, possible salutary effects of factors that play a role in energy preservation, resistance to deleterious effects of inflammation, and enhanced muscle mass and body composition. Given that ESRD is associated with significantly increased risk for morbidity and mortality, understanding the pathophysiologic mechanisms responsible for the obesity paradox across race-ethnic populations might help identify potential therapeutic targets that can be used to improve survival in this patient population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available